Keyword: Tumor

News

FDA Approves NuvOx IND Brain Tumor Trial

18.04.2017 - The US Food and Drug Administration (FDA) has approved NuvOx Pharma’s application to proceed with Phase 2 clinical trials for an Investigational New Drug (IND) to initiate a Phase...

Markets & Companies

The Future Lies in the Genome

07.10.2015 - Kemal Malik, board member for innovation at the German Bayer Group, sees many similarities in the genetic system of humans, animals and plants. This opens the door for synergies in...